<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02030756</url>
  </required_header>
  <id_info>
    <org_study_id>Vibrant-14-MS-CTIL</org_study_id>
    <nct_id>NCT02030756</nct_id>
  </id_info>
  <brief_title>Performance, Efficacy and Safety of Vibrating Capsule in Aiding Constipated Individuals</brief_title>
  <official_title>Assessment of the Performance, Efficacy and Safety of Vibrating Capsule Medical Device in Aiding Reliving Constipated Individuals.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vibrant Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vibrant Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a study intended to evaluate the efficacy and safety of the vibrating capsule versus
      sham non-vibrating capsule on spontaneous bowel movement, in aiding reliving Constipated
      Individuals
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2014</start_date>
  <completion_date type="Actual">February 2016</completion_date>
  <primary_completion_date type="Actual">January 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Frequency of bowel movements</measure>
    <time_frame>3 months</time_frame>
    <description>change from baseline in the weekly Spontaneous Bowel Movement (SBM) rate during treatment period. Success will be defined as increase by at least 1 SBM/week. The primary analysis will be a comparative analysis of success rates between the study groups</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">144</enrollment>
  <condition>Chronic Idiopathic Constipation</condition>
  <arm_group>
    <arm_group_label>Vibrating capsule</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients will receive vibrating capsule for 8 weeks of treatment [1 every 3 days (+/- 1 day)].</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sham non-vibrating capsule</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>patients will receive sham non-vibrating capsule for 8 weeks of treatment [1 every 3 days (+/- 1 day)].</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>vibrating capsule</intervention_name>
    <description>patients will receive vibrating capsule for 8 weeks of treatment [1 every 3 days (+/- 1 day)].</description>
    <arm_group_label>Vibrating capsule</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>sham non-vibrating capsule</intervention_name>
    <description>patients will receive sham non-vibrating capsule for 8 weeks of treatment [1 every 3 days (+/- 1 day)].</description>
    <arm_group_label>sham non-vibrating capsule</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients aged 18 years and older.

          2. Patients with chronic idiopathic constipation according to Rome III criteria and who
             have not experienced relief of their symptoms from available therapies (osmotic and
             stimulant laxatives which was used for at least one month at recommended dose).

          3. Patients with more than 1 bowel movement/2 weeks and &lt; 3 bowel movement/week.

          4. Colonoscopy performed in the past 10 years prior to study participation, unless the
             patients are &lt;50 years old and without alarming signs and symptoms

          5. Patient signed ICF

          6. For women with childbearing potential, adequate contraception

        Exclusion Criteria:

          1. History of complicated/obstructive diverticular disease

          2. History of intestinal or colonic obstruction.

          3. History of significant GI disorder.

          4. Use of following medication: Medication that may affect the bowel mobility,
             Prokinetics, Anti-Depressants, medications for treatment of Parkinson disease,
             Opiates, Calcium-channel Blockers, Aluminium/Magnesium Hydroxids

          5. Clinical evidence of significant respiratory, CVS, renal, hepatic, biliary, endocrine,
             psychiatric, neurologic, or presence of abdominal pacemakers.

          6. Presence of pacemaker.

          7. History of, or current eating disorders, such as anorexia, bulimia, or compulsory
             overeating.

          8. Diagnosis of mega-rectum or colon, a history of intestinal obstruction, congenital
             anorectal malformation, clinically significant rectocele, or any evidence of
             intestinal structural abnormality, including GI resection that affects bowel transit,
             or any evidence of intestinal carcinoma or inflammatory bowel disease of alarm
             symptoms such as weight loss, rectal bleeding, or anaemia.

          9. History of Zenker's diverticulum, dysphagia or a known esophageal stricture 10.
             Chronic use of non-steroidal anti-inflammatory drugs (NSAIDs)

        11. Participation in another clinical study in the last 4 months prior to screening.

        12. Any other condition which in the opinion of the investigator may adversely affect the
        safety of the patient or would limit the patient's ability to complete the clinical study.

        13. Women who are pregnant or lactating.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Borland-Groover Clinic</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32256</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Georgia Regents University</name>
      <address>
        <city>Augusta</city>
        <state>Georgia</state>
        <zip>30912</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MGG Group Co., Inc., Chevy Chase Clinical Research</name>
      <address>
        <city>Chevy Chase</city>
        <state>Maryland</state>
        <zip>20815</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mgh Boston</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Michigan Hospital</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Albuquerque Neuroscience</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NYU Langone Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Temple University School of Medicine</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19140</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CTRS LLC</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15206</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Huoston Methodist Hosptial</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bat-Yamon</name>
      <address>
        <city>Bat Yam</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Degani center Clalit MC</name>
      <address>
        <city>Hadera</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Expert clinic Clalit MC</name>
      <address>
        <city>Herzliya</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Talpiot clinic Clalit MC</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Zvoulon MC Clalit MC</name>
      <address>
        <city>Kiryat Bialik</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>100 Tower</name>
      <address>
        <city>Tel Aviv</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Souraski Medical Center</name>
      <address>
        <city>Tel Aviv</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 7, 2014</study_first_submitted>
  <study_first_submitted_qc>January 7, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 8, 2014</study_first_posted>
  <disposition_first_submitted>October 31, 2017</disposition_first_submitted>
  <disposition_first_submitted_qc>October 31, 2017</disposition_first_submitted_qc>
  <disposition_first_posted type="Actual">November 6, 2017</disposition_first_posted>
  <last_update_submitted>November 5, 2017</last_update_submitted>
  <last_update_submitted_qc>November 5, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 7, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>constipation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constipation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted, but a results disposition has been submitted           -->
</clinical_study>

